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Abstract
Affymetrix three-prime expression microarrays contain thousands of redundant probe sets that interrogate different regions
of the same gene. Differential expression analysis methods rarely consider probe redundancy, which can lead to inaccurate
inference about overall gene expression or cause investigators to overlook potentially valuable information about
differential regulation of variant mRNA products. We investigated the behaviour and consistency of redundant probe sets in
a publicly-available data set containing samples from mouse brain amygdala and hippocampus and asked how applying
filtering methods to the data affected consistency of results obtained from redundant probe sets. A genome-based filter
that screens and groups probe sets according to their overlapping genomic alignments significantly improved redundant
probe set consistency. Screening based on qualitative Present-Absent calls from MAS5 also improved consistency. However,
even after applying these filters, many redundant probe sets showed significant fold-change differences relative to each
other, suggesting differential regulation of alternative transcript production. Visual inspection of these loci using an
interactive genome visualization tool (igb.bioviz.org) exposed thirty putative examples of differential regulation of
alternative splicing or polyadenylation across brain regions in mouse. This work demonstrates how P/A-call and genome-
based filtering can improve consistency among redundant probe sets while at the same time exposing possible differential
regulation of RNA processing pathways across sample types.
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Introduction
Expression arrays from Affymetrix contain hundreds of
thousands of oligonucleotide probes grouped into functional units
called probe sets, where each probe set is designed to measure the
expression of a known or computationally-predicted mRNA target
molecule. Affymetrix sells two commonly-used types of expression
arrays: three-prime arrays in which probe sets are designed against
the three-prime region of a single mRNA target, called a
consensus sequence in Affymetrix parlance, and exon-focused
arrays in which probe sets are designed to interrogate individual
exons. Currently, the majority of mammalian expression data in
the Gene Expression Omnibus (GEO) are from three-prime
arrays, especially the mouse 430 and human u133 series, and these
arrays continue to be used in individual labs as well as larger-scale
projects, such as the Cancer Genome Atlas [1]. Exon arrays were
developed more recently and have been marketed as being able to
quantify changes in alternative splicing. Many groups have
reported success using exon arrays in this way, while others have
explored alternative designs in which probes span exon-exon
junctions and interrogate individual splicing events. In this paper,
we argue that the three-prime arrays, although they were not
designed specifically for this purpose, may have some value in the
study of alternative transcripts, thanks to the large number of
redundant probe sets present on many of these arrays.
Redundant probe sets are probe sets that measure different
regions of the same target gene. As described in their product
literature, the Affymetrix probe set design procedures for the
three-prime arrays attempt to generate probe sets for all known or
inferred expressed sequences. As a result, many of the three-prime
arrays contain a large proportion of redundant probe sets that
interrogate potential alternative forms of transcripts arising from
the same gene. In most cases, redundant probe sets reflect
differential three-prime end processing, since probes have typically
been selected from regions near the three-prime ends of the target
transcripts. For example, D’mello et al. [2] compared human,
mouse, and rat Affymetrix GeneChips probes and probe sets to
polyadenylation sites predicted from ESTs. They concluded that
alternative polyadenylation may affect expression analysis of a
large number of target genes (13%–35%) on each array.
Probe set redundancy can cause problems for microarray data
analysis when different probe sets addressing the same gene
produce inconsistent results. For example, if only one of a set of
redundant probe sets appears differentially-expressed, should this
lessen confidence that the gene itself is changed in response to the
treatment being investigated in an experiment? How should an
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differentially-expressed, but in opposite directions? Such questions
have largely been overlooked in most real-world analyses, mainly
because commonly-used analysis protocols operate at the level of
the probe set and incorporate probe set-to-gene annotations late in
the process. It is not clear how how an investigator should
interpret redundant probe sets that generate discordant results,
which is one of the problems we address in this paper.
The most biologically-interesting and straightforward explana-
tion for inconsistency among redundant probe sets is that the
experimental condition under investigation has induced a change in
the relative concentration of mRNA variants detected by the
discordant probesets. However, this interpretation is cloudedby the
fact that some redundant probe sets are not intended to measure
variants of the same gene. For example, some redundant probe sets
are merely designed to measure opposite strands of the same gene
when the array design process was unable to determine the genomic
strand of a transcribed sequence. In other cases, redundant probe
sets map to the same strand of the same gene region, but their target
sequences do not overlap and therefore are unlikely to be variants of
the same transcriptional unit. For example, Stalteri and Harrison
[3] described in detail the mouse Surf4 gene that was associated with
eightprobesetsontheMOE430Achip.Asdescribedintheirarticle,
two out of the eight probe sets actually hybridize to transcripts
arising from a different but related gene (Surf2) transcript. Our
analysis of the redundant probe sets on the Arabidopsis ATH1 chip
using a large collection of microarray data showed that some of the
lack of concordance between the profiles from the redundant probe
sets is likely associated with incorrect gene models and annotation
problems [4]. Thus, the potential ability of redundant probe sets to
shed light on regulation of mRNA variants is somewhat clouded by
ambiguities in annotation, i.e., mapping probe sets onto their
putative target genes.
Previously Affymetrix reported probe set-to-target gene map-
pings primarily as mappings between Unigene identifiers (ids) and
probe set ids, reflecting the transcriptome-centric nature of the
Affymetrix probe set design pipeline [5]. However, as genomic
sequence has become available, Affymetrix has shifted toward a
more gene-centric approach, reporting mappings between Entrez
Gene ids and probe sets in addition to mappings between probe set
ids and putative target transcripts. Because new sequences are
constantly added to the public databases, the probe set-to-target
mappings require constant updating to reflect the new data, and
Affymetrix obliges this requirement via periodic new releases of
probe set annotations. One group tracking these new releases
showed that 5% of the Affymetrix probe set-to-gene annotation in
Affymetrix’ NetAffx database had changed over a two-year span
[6]. Other groups besides Affymetrix have also tackled the
problem of probe set annotation and target gene identification.
Some of these efforts have helped to expose problematic or
potentially faulty probes, such as probes that map to multiple
locations in the genome or, conversely, probes that do not appear
to map to any location within the designated target locus. Studies
that have investigated problematic probes have demonstrated that
removing them from estimates of target mRNA abundance
profoundly affects analysis results [3,7,8].
In this paper, we investigate redundant probe set consistency in
a data set harvested from the Gene Expression Omnibus [9]. We
investigate the degree to which redundant probe sets, determined
using default probe set annotations provided by Affymetrix,
exhibit discordant results. We assess how genome-based and
qualitative present/absent (P/A) screening methods affect probe
set consistency, using different measures of differential expression.
We use an ANOVA-based method to detect target genes whose
redundant probe sets show significantly different fold-changes across
experimental conditions. We then visually-inspect these target genes
using an interactive genome display tool and determine if
independent evidence for alternative splicing or polyadenylation is
available. In general, we find that eliminating problematic probe sets
through genome-based screening, followed by application of
present/absent call filtering, results in an overall increase of
consistency among redundant probe sets, leaving only the most
interesting cases for further analysis and experimental verification.
Methods
Affymetrix-provided redundant probe set groupings
A file containing annotations for the Mouse 430_2 array was
downloadedfromAffymetrix.Thefile(Mouse430_2.na22.annot.csv)
reports zeroor moreEntrez Gene ids for each probeset. Thus,probe
sets mapping to the same gene id represent redundant probe sets
according to Affymetrix’ in-house annotation pipeline. Out of
45,101probesetslistedinthefile,36,431werelistedashavingoneor
more target genes. A group of probe sets that match the same target
gene are designated redundant probe sets. (Note that MOE430 and
430_2 are alternative designations for the same array design.)
Genome-based grouping and screening procedures
We obtained mouse genome (mm8) alignments for Affymetrix
MOE430 probe set consensus sequences from the UCSC Genome
Bioinformatics Table Browser in ‘‘bed’’ (browser extensible format)
and fasta formats. The ‘‘bed’’ file describes the pattern of aligned
blocks between matching segments of consensus and genomic
sequence, and the fasta file contains concatenated segments of
genomic sequence as defined by these alignment blocks. Probe sets
withconsensus alignments that mappedto a single genomic location
within the assembled chromosomes were retained. We obtained
probe sequences for the Mouse 430_2 array from Affymetrix and
then computed the coordinates of each probe’s position within the
corresponding genome-based fasta sequences. Consensus align-
ments that contained all eleven probes were noted and carried
forward for subsequent statistical analysis. Finally, we trimmed the
alignments such that they included only the regions bounded by the
five- and three-prime most probe positions. For visualization of the
trimmed target regions and probes, we converted the trimmed
alignments into Affymetrix’ ‘‘link.psl’’ format and viewed them in
the Integrated Genome Browser, an open source, freely-available
interactive desktop genome browser tool (http://igb.bioviz.org).
The ‘‘link.psl’’ file is available from http://www.transvar.org/
results/reanal/MOE430.trimmed.link.psl.
In parallel, we obtained mRNA-to-genome alignments from the
UCSC Genome Bioinformatics Web site using the Table Browser
tool. mRNAs that mapped to a single genomic location were
included in subsequent steps. The mRNA-to-genome and
trimmed probe set consensus sequence alignments were then
sorted into groups such that at least one alignment block from each
group member overlapped with one or more blocks from at least
one other alignment in the same group. The biological rationale
for this is that alignment blocks in mRNA alignments represent
exons, and when these exons overlap, this is reasonably good
evidence that they originate from the same gene region or
transcriptional unit. When a trimmed, probe set consensus
sequence alignment overlaps with one or more mRNAs in a
group, the probe set is then considered to interrogate the same
gene region or transcriptional unit as defined by the mRNAs’
pattern of alignment. When two or more trimmed, probe set
consensus sequences belong to the same group, these probe sets
are considered redundant because they measure the same gene
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Entrez Gene id-to-mRNA accession mappings were obtained from
NCBI (the gene2accession file from the Entrez Gene ftp site) and
then added to each gene grouping.
Data S1 lists groupings for screened probe sets, and Data S2
summarizes results from the screening steps. In the latter file,
probe sets whose consensus sequences mapped to one or no
genomic positions receive mapping codes ‘‘SM’’ or ‘‘NM’’
respectively, and probe sets mapping to multiple positions are
annotated with code ‘‘MM.’’ For all ‘‘SM’’ probe sets, the number
of probes perfectly matching the genomic sequence within the
region defined by the probe set consensus alignment is reported.
Microarray data set
Array data files (.CEL files) for expression microarray data set
GSE4035 were obtained from the Gene Expression Omnibus.
This experiment profiled the gene expression in the amygdala and
hippocampus dissected from mice from two different strains that
exhibit distinct responses to fear conditioning (high and low
tolerance). Each brain region for each reaction level was
represented by six biological replicates. For the redundant probe
sets and differential expression analysis, brain regions were
compared only between mice from the same strain [10]. We
selected this data set in because of its relatively high level of
replication (six arrays per group) and observations that alternative
mRNA processing is unusually prevalent in neural tissue.
Array pre-processing
Probe intensity data from each data set were imported into the R
environment (http://www.R-project.org) directly from .CEL files
using the affy package [11] in Bioconductor (http://www.
bioconductor.org/). The affy package was also used to create
expression summary measures. Briefly, weadjusted the background
of perfect match (PM) probes, applied a quantile normalization of
the corrected PM values, and calculated final expression measures
using the robust multi-array average (RMA) method [12]. Pre-
processing was performed on all chips in the data set together.
Present/absent call filtering
In cases where Present/Absent filtering was conducted, P/A call
for each probe set on each chip was obtained using the MAS 5.0
method implemented in the affy package with default settings
unless specified. To be designated ‘‘present’’ in differential
expression analysis, a probe set needed to have at least 80% of
replicate samples called as present in at least one sample type.
Probe set-level differential expression analysis
To estimate effects of each brain region and test for the region
effect, we split the data according to fear reaction levels and then
fit a model to the data from each probe set. For each subset of data
we fit a fixed effect one-way ANOVA model, yij~mzRizeij,t o
the pre-processed expression level of each probe set. Here m is the
overall mean; Ri is the deviation of the i
th (i=1,2) brain region
from the overall mean; and eij is the residual. We used a shrinkage-
based t test [13] to test the brain region effect (Ri). The empirical
distribution of the shrinkage-based t statistic was established
through permutation analysis, where the rows of the design matrix
corresponding to the tested term (Ri) were shuffled 1000 times
randomly while the data were kept unchanged [13,14]. The
shrinkage t statistics calculated from the permutations were pooled
across genes that are not significant [15] at nominal 0.1 level
according to a conservative gene specific t test to form one overall
empirical distribution. The percentile of the shrinkage t from
observed data in the empirical distribution provides an estimate of
the p-value for each gene. Gene lists were generated using a false
discovery rate (FDR) of 0.005 [16] unless otherwise specified.
Comparing redundant probe sets
Todetermine whentworedundantprobesetsmeasuringthe same
gene generate discordant results, we formally tested whether the
redundant probe sets produce different fold changes. One way to
achieve this is to test whether the signal differences between
redundant probe sets have a significant brain region effect. In other
words, we compare the fold-change between tested groups (brain
region, in this case) exhibited by two redundant probe sets and ask if
they are significantly different. If two probe sets yield similar fold-
changes, the differences will not show a significant group effect. If
two probe sets generate different fold-changes, this indicates possible
differential regulation of probe set targets. To test for different fold-
changes, we first take the difference between the probe sets on the
same chip after data pre-processing and then fit the ANOVA model
used above for differential expression to the differences. The test of
significance for the term of interest (Ri) provides information on
whether the targets of the two redundant probe sets are affected by
this term differently. This method is a modified version of the
ANOSVA methods by Cline et al. [17], adapted for pairwise probe
set comparisons. The modification allows identification of specific
pairs of disagreeing probe sets, a necessary first step toward
identification of differentially-processed targets.
Significance consistency index
We developed a significance consistency index of the redundant
probe sets to summarize the overall degree to which redundant
probe sets generate consistent results in a test for differential
expression. This allows one to assess probe set-to-gene target
annotations across the full set of probe sets in a given array. For a
single group of redundant probe sets targeting i
th gene gi, the
consistency index was calculated as the proportion pi of redundant
probe sets found to be significant with respect to differential
expression. Only probe set groupings where there was at least one
significant probe set were included in consistency index calcula-
tions. Averaging individual redundancy probe set group consis-





, where pi is
the proportion of probe sets that are significant for gene gi
(i=1,…,G) and G is the total number of associated multi-probe set
target genes being tested on an array in which at least one probe
set was found to be significantly changed. Thus, values closer to
one indicate greater overall agreement among redundant probe
sets across all genes G represented on an array.
Re-sample procedure assessing effects of sampling
variation on probe set pair differences
We used a re-sampling approach to assess the effects of sampling
variation on fold-change and P/A call consistency between
redundant probe sets. To simulate variation arising from random
sampling, we created sub-data sets from arrays in two different
experiment groups: amygdala and hippocampus samples harvested
from the low fear strain, where each group contained six replicate
arrays. For this, we randomly-selected three arrays from each group,
forming a single sub-data set of six arrays, including a three arrays
from group one (S1a - low fear amygdala) and three arrays from
group two (S1h - low fear hippocampus). The remaining six arrays
formed a second sub-data set (S2a and S2h). For each round of
sampling, we assessed consistency using summary statistics compar-
ing sub-data sets and redundant probe sets. We repeated the sub-
Redundant Probe Sets Analysis
PLoS ONE | www.plosone.org 3 January 2009 | Volume 4 | Issue 1 | e4229setting procedure twenty times and calculated the average and
variance for each measure. For simplicity, we considered probe sets
with only one redundant partner probe set.
The summary statistics included: (1) PA-consistency for
redundant probe sets, calculated as the percentage of redundant
probe set pairs where each probe set in the pair had the same PA
call in the two sub-data sets; (2) PA-consistency for single probe
sets, calculated as the percentage of probe sets that had the same
PA-call in the two sub-data sets; (3) Fold-change correlation for
redundant probe sets, computed as the correlation of fold-changes
pairs corresponding two redundant probe sets harvested from S1
and S2 array triplets, where fold-change (amygdala versus
hippocampus) was calculated using array triplets from each sub-
data set separately; (4) Fold-change correlation for individual
probe sets, calculated as the correlation between fold-changes
obtained from S1 versus S2; (5) No. of redundant probe sets pairs
where both probe sets in the pair were significantly changed across
brain regions (FDR 0.05), within the same sub-data set S1 or S2; (6)
Number of individual probe sets that were significantly changed
(FDR 0.05) across brain regions in both sub-data sets S1 and S2.
Note that one caveat to this random sampling approach is that
the power to detect differential expression across brain regains test
using the sub-data sets decreases is reduced in the sub-data sets
because of the smaller number of replicates, e.g., reduced from six
to three. Therefore, for this analysis, we adjusted the stringency for
identifying differential probe sets to FDR 0.05.
Results
Affymetrix provides annotation files mapping individual probe set
onto Entrez Gene ids; these annotations are widely used in publicly-
available databases (such as the Gene Expression Omnibus) and in
microarrayanalysissoftwarepackagessuchasthoseinBioconductor.
These annotation files report Entrez Gene ids for many probe sets,
and probe sets that are annotated with the same Entrez gene id
represent redundant probe sets as determined by Affymetrix. Using
matching of Entrez gene ids, we obtained a list of Affymetrix-
designated redundant probe set groupings where all the probe sets in
the same group match the same gene. These redundant probe set
listings thus provide a baseline against which to evaluate improve-
ments in probe set-to-target gene annotations. As shown in Table 1,
thegeneraldistributionofthenumberofprobesetspergeneishighly
skewed. For example, groups with n probe sets are more than twice
as common as groups with n+1 probe sets.
We developed a genome-based computational pipeline that uses
genomic alignments of mRNAs and probe set consensus sequences
to identify high-quality probe sets and assign these to groups based
on their patterns of genomic overlap. The goal of the pipeline is to
generate a highly stringent set of annotations and make
downstream, gene-by-gene analysis steps less perilous (Figure 1).
Briefly, the method uses publicly-available genomic alignments to
define probe set interrogation regions within the genomic
sequence. Next, it searches for probe locations within the fasta
sequence from concatenated genomic sequence defined by
alignment blocks. Probe sets whose probes are omitted from the
fasta sequence are flagged as questionable and omitted from the
final list of ‘‘cleaned’’ probe sets. Using this procedure, we found
that 94% of probe set consensus sequences on the Mouse 430_2
array mapped to a single genomic location. Of these, 86%
contained all eleven probes in the genomic sequence.
We then used consensus and mRNA genomic alignments to sort
the screened probe sets into redundant probe set groupings such
that members of each group measure the same gene. Using this
procedure, we identified around 5,000 genes or gene regions that
were interrogated by two or more cleaned redundant probe sets
for the MOE430 array. Compared with the groupings based on
Affymetrix annotation, the groupings generated this way have
many fewer genes with redundant probe sets (Table 1). Also, the
group sizes tend to be smaller. The largest group contains 8 probe
sets. In contrast, a substantial number of groups from Affymetrix’
annotation file have more than 8 redundant probe sets, while
others have as many as 15 probe sets.
Redundant probe set consistency
Affymetrix microarray expression data are commonly analyzed
probe set by probe set. If the redundant probe sets for a given gene
indeed measure the same target transcripts, then they should yield
consistent results in the same experiment with the allowance of
some variation. We tested this expectation by examining present-
absent call consistency, significance consistency, and fold change
consistency across redundant probe sets in a relatively well-
replicated, real-life data set (GSE4035) harvested from the Gene
Expression Omnibus and generated using the mouse MOE430
array from Affymetrix. The data set consists of six samples per
experimental grouping, where the groups consist of samples from
different brain regions (amygdala and hippocampus) from two
different strains of mice that exhibit differential fear responses. For
differential expression analysis across sample types, we compared
different brain regions dissected from the same mouse strain, thus
avoiding complications due to genetic differences between strains.
Consistency of present and absent calls
Affymetrix probe sets include perfect match (PM) probes that
are identical to the probe set’s intended target, as well as
corresponding mis-match probes (MM) that contain a single base
pair difference. The MM probes are believed to provide an
estimate of non-specific hybridization that presumably affects the
PM and MM probes equally. Comparing hybridization intensity
of PM and MM probes allows assessment of the overall signal
strength of a probe set. The low PM signals relative to MM probes
Table 1. Number of genes with redundant probe sets before
and after filtering out the absent probe sets.
# of prs/gene AG AGP GG GGP
2 5,133 2864 3767 2337
3 2,427 1228 1173 677
4 1,181 496 353 205
5 556 256 105 55
6 305 99 25 10
7 144 35 7 3
86 9 1 8 1 0
9 3 0400
10 15 0 0 0
1 1 7 000
1 2 4 000
1 3 3 000
1 5 1 000
Total # genes 9875 5000 5431 3287
AG and GG indicate the original Affymetrix grouping and genome-based
groupings, respectively. AGP and GGP represent the AG and GG groupings in
which only probe sets called as ‘‘Present’’ were included in the final groupings.
The abbreviation ‘‘prs’’ means: ‘‘probe sets.’’
doi:10.1371/journal.pone.0004229.t001
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algorithms in the MAS5.0 software from Affymetrix [18]. The
consistency of the P/A calls between probe sets interrogating the
same gene provides an indicator of how differently the redundant
probe sets from the same gene behave at this level. We ran the P/
A call algorithm on all arrays and examined the consistency of P/
A calls between redundant probe sets on the same array. We found
that, on average, only about 50%–60% of probe sets are called as
present, which is similar to the overall proportion of expressed
genes in most tissues [19]. We found that redundant probe sets
measuring the same gene (as designated by Affymetrix) frequently
received different P/A calls. For example, genes with two
redundant probe sets assigned by Affymetrix grouping showed
inconsistent P/A calls in 31% of the genes. However, the
redundant probe sets based on the genome-based groupings
showed lower (only 26%) P/A call inconsistency. Overall, we
found that P/A calls for the genome-based groupings were
generally more consistent than for the Affymetrix groupings.
Significance Consistency of redundant probe sets
Expression microarray data analyses from Affymetrix arrays
generate lists of significantly-changed probe sets, and when one or
more of a gene’s matching probe sets appear in the list, then the
target gene is typically considered to be differentially expressed.
Because redundant probe sets may interrogate different transcripts
arising from the same gene, examining the consistency of
redundant probe sets that are included or excluded from the
significant probe set list may expose biologically-interesting
features of the data, such as evidence of differential mRNA
processing. Using a relatively stringent significance level
(FDR=0.005) for selecting significant probe sets, we identified
4,982 and 8,952 significant probe sets that were differentially
expressed between the amygdala and hippocampus samples in the
low and high reaction levels in the GSE4035 data set. The overlap
among these two lists is very high, with 4,041 probe sets in
common. The fold changes obtained from these two reaction
levels are also very similar (Data S3). For simplicity, we focused on
the low reaction level alone for the significance consistency
analysis. Among the 4,982 significant probe sets, we found that
3,193 probe sets were from genes that have two or more probe
sets, as judged by our genome-based grouping and screening
procedure. To determine the consistency of these redundant probe
sets in terms of differential expression, we examined the presence
or absence of all redundant probe sets in the significant list. We
found that only a small proportion of the genes with at least one
significant probe set have all probe sets significant, while the
majority of them show inconsistent results from the redundant
probe sets (Data S4). The results obtained from the high reaction
level are similar to that of the low reaction level presented here.
To summarize the overall consistency of the redundant probe
sets in terms of whether they are significant, we calculated the
consistency index using genes with redundant probe sets where at
least one probe set was identified as significantly-changed between
compared groups. Figure 2 shows that the majority of the
redundant probe set groupings have consistency index less than
one. The large proportion of genes with consistency index of 0.5 or
1 is due to the fact that most genes in our groupings have only two
probe sets and at least one of them is significant for this calculation
(Table 1). Compared with the Affymetrix grouping scheme, the
genome-based grouping has a larger proportion of genes showing
higher consistency and smaller proportion of genes showing lower
consistency. We also computed the average consistency score
across all genes. It is 0.60 when genome-based grouping was used.
However, it is 0.50 when the Affymetrix grouping was used. The
larger consistency index obtained for the genome-based grouping
indicates that this probe set screening procedure increases the
consistency across redundant probe sets. Considering that the
consistency index may change when different FDR thresholds are
used for identifying differentially expressed probe sets, we also
examined the overall consistency index at various FDR thresholds
(Figure 3). We found that the consistency index increases as the
FDR threshold decreases. However, regardless of the FDR
threshold, the consistency index of the genome-based grouping
exceeds that of the Affymetrix grouping, although the difference
decreases with increasing FDR.
Removing absent probe sets improves redundant probe
set consistency
It was demonstrated previously that filtering out probe sets that
are deemed as absent (P/A filtering) before conducting further
statistical inference benefits identification of differentially expressed
genes [20].To test the effects of P/A filteringon redundant probe set
consistency, we removed probe sets that were deemed as absent by
MAS5.0 present/absent call [21] and only analyzed the redundant
probe sets that were deemed present. When we recomputed the
significance consistency index for the present redundant probe sets
and excludedabsent probe setsfrom the calculations,theconsistency
index increased dramatically. Figure 2 shows that removing the
Figure 1. Scheme for genome-based redundant probe sets
grouping. Genomic alignments for probe set consensus sequences are
tested for instances of probe sequences within the genomic portion of
the alignment. For all probe sets whose consensus sequence
alignments contain all eleven probes, a new trimmed target region
genomic alignment is generated bounded by the five and three-prime-
most probe sequences. In parallel, genomic alignments for mRNA are
combined into groups based on genomic overlap patterns. The
trimmed target region alignments are then compared with the exon
overlap groups from the mRNA branch of the pipeline. All probe set
target sequence alignments that overlap with at least one member of
the mRNA exon overlap groups are then annotated as targeting the
given group. Probe sets interrogating members of the same exon
overlap group are designated redundant probe sets.
doi:10.1371/journal.pone.0004229.g001
Redundant Probe Sets Analysis
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geneswithhigherconsistencyanddecreasedtheproportionsofgenes
with lower consistency. The significance consistency index for the
genome-based grouping increased from 0.60 to 0.65 with P/A
filtering. For the Affymetrix grouping, P/A filtering increased the
consistency index from 0.50 to 0.59.
To further examine the relationship among P/A calls, significant
probe sets, and consistency of the redundant probe sets, we
examined in detail the genes with two probe sets. In general, probe
sets that indicate differential expression are also called as Present by
MAS5.0 (Table 2). For the 2,002 genes with both probe sets called
as present (P/P category in Table 2), about 22% (884) of the probe
sets were significantandmore than 57% ofthe884significantprobe
sets were from the same genes. In contrast, for genes with both
probe sets absent (A/A category), only three probe sets from the 834
genes were significant and each of these three significant probe sets
were from different genes. For genes with one present probe set and
one absent probe set (P/A category), 9.6% (178) of the probe sets
fromthe931 genesweresignificantand13%ofthesignificantprobe
sets werefromthesame gene.Inaddition,thesignificantprobe setis
the present probe set in most cases (147 out 154). These results
indicate that the significant probe sets and the significance
consistency among redundant probe sets come mainly from the
present probe sets, which explains why removing absent probe sets
improves the overall consistency of redundant probe sets. We also
formally tested whether the proportions of significant probe sets in
eachofthethree categories inTable 3(P/P,P/A, A/A)aredifferent
using a McNemar test [22] and obtained extremely high
significance (with p values less than 2.2610
216). The same test
was also conducted to test the proportions of significant probe sets
that are from the same gene across the three categories (P/P, P/A,
A/A), and the result was also extremely highly significant (with p
values less than 2.2610
216). These tests confirm that absent probe
setsindicatedifferentialexpressiontoa lesserdegreethan dopresent
probe sets and that removing absent probe sets increases redundant
probe set agreement.
Figure 2. The distribution of genes with various significance
consistency index values. A consistency index was calculated for
each gene with multiple probe sets and at least one probe set
significantly different across compared groups. The y-axis indicates the
proportion of genes with the consistency index indicated on the x-axis.
AG and GG refer to Affymetrix groupings and genome-based
groupings, respectively. AGP and GGP refer to AG and GG groupings
in which only probe sets called as ‘‘present’’ were included in the
calculation. Significance level is FDR 0.005.
doi:10.1371/journal.pone.0004229.g002
Figure 3. Significance consistency among the redundant probe
sets changes depends on FDR threshold. A consistency index was
computed for each gene with redundant probe sets at different FDR
level. AG and GG indicate the original Affymetrix grouping and
proposed genome-based groupings, respectively. AGP and GGP
represent the AG and GG groupings. AGP and GGP refer to AG and
GG groupings in which only probe sets called as ‘‘present’’ were
included in the calculation.
doi:10.1371/journal.pone.0004229.g003
Table 2. Relationship between P/A calls and significance for
differential expression for genes with two probe sets.
P/P A/A A/P
Total # genes 2002 834 931
Sig probe sets 884 3 178
2 (1) sig prs/gene 253 (378) 0 (3) 12 (154)
P/P, both probe sets are present. A/A, both probe sets are absent. A/P, one
probe set is absent and the other one is present. The abbreviations ‘‘sig’’ and
‘‘prs’’ mean ‘‘significant’’ and ‘‘probe sets,’’ respectively.
doi:10.1371/journal.pone.0004229.t002
Table 3. Consistency of fold changes between redundant
probe set pairs.
Statistics AG AGP GG GGP
Corr. Coef. of FC 0.60 0.74 0.72 0.79
% genes w/ opposite FC direction 0.38 0.28 0.33 0.27
AG and GG indicate the Affymetrix grouping and genome-based groupings,
respectively. AGP and GGP represent the present the AG and GG groupings and
including only present probe sets. The abbreviation ‘‘prs’’ means probe sets. FC
is fold change. Corr. Coef is Pearson correlation coefficient.
doi:10.1371/journal.pone.0004229.t003
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was meant to control the false present calls rate at 0.05, i.e., an
expected false present call rate of 5%. At this rate, the false absent
callcould be high. We increased the false present call rate to 0.1, 0.3,
and 0.5 and examined how these different rates affected consistency
of the redundant probe sets called as present. The overall proportion
of present probe sets increased dramatically from 54% to 82% as the
false present call rate increased. The P/A call consistency between
redundant probe sets increased from 75% to 85% for genes with two
probe sets. However, the overall significance consistency index for
the present redundant probe sets reduced slightly from 0.65 to 0.61
(Data S5). This trend is observed for all the FDR settings in
differential expression analysis (Data S6). These results showed that
increasing the false present call rate resulted in large increase of the
number of present probe sets and large increase of P/A call
consistency with a small decrease of the significance consistency. It
suggests that a higher P/A call threshold might be more appropriate
in routine Affymetrix expression array data analyses.
Fold change consistency among redundant probe sets
Fold change estimation is an important aspect of microarray
analysis. It has been suggested that fold change is more replicable
than p-value based inferences and often has greater biological
meaning [19]. Therefore, we evaluated correlation between the fold
changes obtained from redundant probe sets, focusing as before on
genes with two redundant probe sets (Table 3). We found that the
Pearson correlation coefficients were higher from the genome-based
redundant probe sets (0.72) than from the Affymetrix-defined
redundantprobe sets(0.60). In addition, P/A filtering increased fold-
change correlations. We also examined the proportion of genes in
which the redundant probe sets exhibited fold-changes in the
opposite direction and found that the Affymetrix-defined redundant
probe sets had a higher percentage of opposite-directed fold-changes
(38%) than the genome-based redundant probe sets (33%), and this
difference was reduced by filtering out the absent probe sets. Thus,
we conclude that the genome-based grouping in combination with
P/A filtering improved fold-change correlation among redundant
probe sets and also reduced the proportion of genes whose
redundant probe sets indicated opposite fold change directions.
The above fold-change consistency analysis does not consider the
whether a gene is significantly changed in an experiment. However,
investigators are typically more interested in genes that are
significantly-changed as a result of an experimental condition, tissue
source, or other factor. To evaluate the fold-change consistency for
genes in the significant list, we computed the fold-change correlation
coefficient for genes with two present redundant probe sets such that
at least one of these was significantly different between the two brain
regions. The resulting correlation coefficient of fold-changes for this
subset of redundant probe set pairs is 0.84, which is substantially
higher than the correlation obtained from all genes with two present
redundant probe sets (0.79). Only a very small proportion of probe
set pairs (0.09%) in this group showed opposite fold change
directions. These results suggest that the redundant probe sets from
highly significant genes are generally more consistent. Figure 4
summarizes these results in graphical form.
P/A filtering stringency also affected the correlation of fold
changes from redundant probe sets. For the present redundant
probe sets, the correlations between the fold changes showed
reduction (0.79 to 0.74) as P/A call p value threshold increased
from 0.05 to 0.5. The proportion of genes with opposite fold
change directions also increased from 27% to 30% (Data S5).
These results provide evidence that the decrease of P/A call
stringency also reduces the fold change consistency among the
redundant probe sets called as present.
Comparing consistency between and within redundant
probe sets
Although redundant probe sets are expected to be consistent if
they are interrogating the same transcript in a data set, random
sampling will always introduce some variation. Thus, lack of
consistency between redundant probe sets could arise from variation
due to sampling, rather than a change in the relative concentration
of mRNA targets. To evaluate the plausibility of random variation
due to sampling as a potential cause of the observed discordance
between redundant probe sets, we performed a re-sampling
procedure aimed at simulating variance due to sampling and then
evaluated redundant probe set concordance across the samples. For
this, we separated the six replicates in each brain region (amygdala
and hippocampus) of the low tolerance group into two sub-data sets,
containing three replicates each from the two brain regions. The
consistency of the results obtained from the same probe set
compared to itself across the sub-data sets thus provides a measure
of the variability introduced by random sampling. Comparing this
sampling-induced variability with the variability observed between
redundant probe sets within the same sub-data set then allows an
assessment of whether or not the observed differences between
redundant probe sets are due to sampling variability alone. For
example, if the underlying target molecule differences between two
redundant probe sets do not contribute much to their observed
inconsistency, then the relative consistency for a single probe set’s
behaviour across the two sub-data sets should be similar in
magnitude to the consistency observed between two redundant
probe sets. In other words, we are asking whether redundant probe
sets behave as replicates of each other in the re-sampling scenario.
For each of twenty repeated re-samplings, we calculated
consistency with respect to PA calls, fold-change correlation, and
differential expression twenty times, as described in Methods. The
Figure 4. Fold change comparison across redundant probe
sets. We first tested each probe set on the array for the brain region
effect and identified a list of significant probe sets using FDR 0.005
significance level. We then compared this significant probe set list with
the list of genes with two present redundant probe sets according to
genome based grouping. For genes with at least one significant probe
set, we plotted the two fold changes (on log scale) against each other
with random naming of probe set1 (prs1) and probe set2 (prs2) in a
gene. Genes with one significant probe set are presented by points.
Genes with two significant probe sets are represented by circles. We
also tested the two fold changes obtained from each probe set for
genes with two redundant probe sets using FDR 0.05 significance level
as described in Methods. Genes that show significant difference in their
fold changes are represented by red V.
doi:10.1371/journal.pone.0004229.g004
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Table 4. The results show that P/A calls for single probe sets are
extremely consistent across sub-data sets; we found that, on
average, around 95% of probe sets are called as either Present or
Absent insubsets taken from the same brain region. In contrast, only
60% of redundant probe sets are both called as Present or Absent.
We observe a similar pattern with respect to fold-change correlation.
Average fold-change correlation for individual probe sets calculated
across sub-data sets was 0.956, while average correlation for
redundant probe sets was 0.860. We also examined the number of
genes in which both redundant probe sets were significant in the
same test versus the number of probe sets significant in both subset
data tests. The average number of genes with same probe set
significant in both tests is 380 while the number of genes with both
redundant probe sets significant in both tests is 301. In every
simulation, the former was larger than the latter. These results
indicate that the consistency across tests of different sub data sets for
a single probe set ismuchhigher thanthat between redundant probe
sets within a test. The inconsistency is probably largely due to the
nature of the redundant probe sets and their targets rather than due
to random experimental variation.
Redundant probe sets that give significantly different
fold-changes
If redundant probe sets show very different response to the
treatment or condition, interesting biological phenomena, such as
splicing or polyadenylation variants that respond to treatment or
condition differently, may be revealed. Therefore, it is interesting
to identify those redundant probe sets for further exploration. To
achieve this, we used an ANOVA model (described in Methods) to
examine some redundant probe set pairs for which both probe sets
in the pair received a MAS5 ‘‘Present’’ call. Using a shrinkage-
based t test, we found that 70 probe set pairs that showed
significantly-different fold-changes between the two brain regions
relative to each other (Figure 4). Interestingly, many of these pairs
included probe sets that were not found to be themselves
differentially-expressed across brain regions. These results suggest
that even if one or both probe sets in a redundant pair do not
suggest differential expression in isolation, together they may
indicate a condition-dependent change in the relative concentra-
tions of individual probe set target transcripts.
We examined the 70 genes with significantly different fold
changes between the two redundant probe sets using the Integrated
Genome Browser (IGB), an interactive genome visualization tool
that can show probes and probe sets together with genomic
sequence and sequence annotations (http://igb.bioviz.org). Using
the Browser, we examined the probe target regions and compared
these to the knownGene annotations harvested from the UCSC
Genome Informatics Table Browser. We found that 29 of the 70
probe set pairs appeared to distinguish between different transcript
variants according to knownGene mRNA annotations. In these
cases, the relative expression of alternative transcript forms could
differ across brain regions. In 5 cases, probe sets did not appear to
overlap with any known genes or were associated with a pair of
mRNAs that overlapped only across their 3-prime and 5-prime
regions and therefore unlikely to be transcribed from the same
promoters. (Note that mRNAs with this configuration are typically
associated with different Entrez Gene ids; our scheme flags such
cases where redundant probe sets are grouped together with
mRNAs associated with different Entrez Gene ids as ‘‘mixed
overlap groups.’’ For a list of these, see Data S1.) In another 4 cases,
the probe sets target very small genes whose known transcripts
encompass one or no introns. The remaining 32 redundant probe
set pairs were associated with only one knownGene mRNA; one
possible explanation for this result is that there may be some
additionalvariant formsthat havenot yetbeendiscovered ornotyet
recorded in the knownGene collection (Data S7).
Redundant probe sets, by definition, interrogate different
regions of the same gene. As a result, they hybridize to different
locations along the same transcripts. Except in cases where probe
sets overlap along the transcript, the difference in the fold changes
revealed by different probe set could also be due to the different
degrees of degradation at different regions of targeted transcripts.
To test this possibility, we examined the RNA degradation
controls on the Mouse430v2.0 chip (Gapdh, b-Actin, TransRec, and
PyruCarb). Each of these control genes has 3 to 4 probe sets located
at the 59end, middle, or 39 end of a single target transcript. We
tested adjacent probe sets and the probe sets at the two ends for
fold change difference across groups using the same procedures
used above in both data sets. No comparison was significant at the
nominal 0.05 level in either data set. This result indicates that
RNA degradation is not likely a major explanation for the different
fold changes across groups exhibited by redundant probe sets in
some genes as shown in Figure 4.
Discussion
Redundant probe sets can complicate analysis of gene
expression, but they may also yield information about how the
relative concentrations of individual transcript variants change in
response to diverse conditions or treatments. However, taking
Table 4. Comparison of consistency across sub data sets and consistency across redundant probe sets based on re-sampling.
Calculation method (see
Methods) Summary statistic Average Std. Dev.
1 PA consistency – redundant probe sets 0.608 0.130
2 PA consistency – same probe set across sub-data sets 0.947 0.018
3 Fold-change correlation – redundant probe sets 0.874 0.009
4 Fold-change correlation – same probe set, across sub-data sets 0.956 0.0094
5 # of redundant probe sets, with both members of the pair significantly different within
a sub-data set
301.1 61.4
6 # of probe sets, significantly different in both sub-data sets 380.1 76.4
The subset of data corresponding to low reaction level were divided into two data sets by randomly sampling 3 out of the 6 biological replicates from each brain region.
Each probe set was individually and with its redundant probe set partner for differential expression, fold-change correlations across and within sub-data sets, as
described in the Methods. The mean and standard deviation were calculated for each summary statistics across twenty re-samplings of the data.
doi:10.1371/journal.pone.0004229.t004
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careful examination of probe set quality and annotations. We used
genomic alignments for the probe set consensus sequences and their
pattern of overlap with reference mRNA-to-genome alignments
provided by UCSC Genome Bioinformatics to screen and group
redundant probe sets such that only probe sets with reliable genomic
mappings remained. This process excluded potentially-flawed probe
sets and, at the same time, grouped the remaining probe sets into
clusters of redundant probe sets based on their mutual overlaps with
mRNA-to-genome alignments harvested from the ‘‘knownGene’’
track of the UCSC Genome Browser.
We tested these genome-based groupings by comparing them to
the Affymetrix-provided redundant probe set groupings in a
differential expression analysis of the GSE4035 data set, which
involvedcomparisonsofgeneexpression betweentwo differentbrain
regions in the mouse. Table 5 provides a summary of several
consistency metrics we evaluated. To summarize consistency among
redundant probe sets measuring the same gene, we developed a
simple metric, the consistency index, defined as the percentage of
probe sets measuring a single gene that are called as differentially-
expressed in an experiment, averaged over all genes with multiple
probe sets. We found that the genome-based redundant probe set
groupings had a higher overall consistency index when compared to
the Affymetrix groupings. As a further measure of redundant probe
set consistency, we computed Pearson’s correlation coefficient
between the fold-changes obtained for the two different probe sets
belonging to each redundant probe set pair. As with the consistency
index, fold-change correlation was higher for genome-based
groupings. In all cases, fold-change correlation and consistency
index improved when only probe sets called as ‘‘Present’’ in 80% or
more samples in a group were considered.
We conclude based on these results that the genome-based
grouping and screening method yields more consistent results for
redundant probe sets. By grouping probe sets based on their
genomic overlaps with known mRNAs, we obtained a more
realistic picture of redundant probe set targets. And by only
considering probe sets whose target regions map precisely to a
single location in the genome which in turn contains perfect
matches for all eleven probes, we help to rule out doubts that
inconsistencies observed between redundant probe sets are due to
cross-hybridization or probe set-design artefacts. Thus, the
genome-based groupings have the potential to reveal biological-
ly-interesting differential regulation of mRNA processing. To
demonstrate this latter idea, we showed how a simple ANOVA-
based method can detect significantly-different fold-changes for
redundant probe sets that measure the same gene. Our application
of the model identified redundant probe set pairs where the probe
sets within a pair yielded significantly-different fold-changes. This
method can be easily extended for genes with more than two
redundant probe sets using a two-way ANOVA model as proposed
by Li et. al., [23]. In the two-way ANOVA model, brain regions
and probe sets are the two factors, and the interaction term of
these two factors will capture the relative target level change
associated with brain region. This two-way ANOVA model differs
from the analysis presented here in that the response variable is the
probe set intensity after normalization, while in the current
analysis it is the difference between redundant probe sets, for genes
with only two redundant probe sets.
Because we applied the test to redundant probe sets as defined
by the genome-based screening and grouping method, we can be
more confident that differences they detect are not mostly due to
mis-annotations but instead may represent bona fide cases of
condition-dependent differential mRNA processing. When we
inspected the gene structures and probe set consensus sequence
alignments using the Integrated Genome Browser, we found that
about half of our findings have redundant probe sets interrogating
different target mRNAs based on the knownGene transcript forms.
Alternative approaches to probe set redundancy have been
developed. One seeks to avoid the complexity of the redundant
probe sets by redefining Affymetrix probe sets in custom Chip
Definition Files (CDFs), so that all probes from redundant probe sets
are assembled into a single probe set [24]. In this case, the analysis is
simplified to just analyzing one (potentially enormous) ‘‘mega probe
set’’ per gene. It has been shown that using these custom CDFs can
improve reproducibility of differential expression analysis between
different laboratories [25]. However, consolidating the redundant
probe sets eliminates the potential ability for individual probe sets to
detect distinct transcripts. Redundant probe sets exist because the
Affymetrixprobesetdesignpipelineforthree-primearraysiscapable
of recognizing and handling transcript variants. The consolidation
strategy perhaps allows for improvements in gene-level differential
expression analysis, but it may eliminate any potential for detecting
bona fide differential regulation of alternative transcripts, e.g., cases
where the treatment under investigation changes the ratio of
alternative forms expressed by the same transcriptional unit.
Similarly, it is not clear if these ‘‘mega probe sets’’ have excluded
Table 5. Summary of redundant probe sets consistency
evaluation.
Evaluated Metric Groups Compared Statistics Used
P/A call Redundant probe
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doi:10.1371/journal.pone.0004229.t005
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interrogating incorrect strand as described for Surf4 [3].
Another strategy is to sub-divide the probe sets into smaller
groups of probes that that interrogate individual exons using prior
knowledge of sequences present in transcript databases [26]. This
strategy tends to generate a large number of probe sets containing
fewer probes. Although this strategy has great appeal, simulation
studies showed that results obtained from probe sets with fewer
than four probes are not reliable, and therefore should be removed
from an analysis. Any remaining probe sets are expected to detect
different transcripts or clusters of transcripts and would therefore
provide transcript-level differential expression measurements.
However, because a large number of rare transcripts (in rare
tissues and conditions) are considered in the same way as common
transcripts, most of the probe sets may not detect particular
transcripts in each experiment. The division of the probe sets may
reduce the power for overall gene expression comparison.
Both the sub-division and consolidation strategies generate
probe sets of unequal sizes, the influence of which on expression
analysis is unknown. While both ideas have some appeal, we
would argue that the probe sets, although some are flawed,
capture real information about sequence variants that existed in
the public databanks at the time the probe sets were designed. For
the purposes of detecting condition-dependent differential mRNA
processing of known variant forms (not detecting unknown
variants), we recommend retaining the Affymetrix defined probe
sets while at the same time depending on the high-quality ones for
more detailed and careful analyses. Similarly, only probe sets that
are truly redundant (e.g., hybridize with transcripts arising from
the same gene or gene region) should be used to address
alternative mRNA processing in Affymetrix 3-prime arrays.
Another recently-published approach involves treating redun-
dant probe sets as replicate measurements of the same gene in an
attempt to improve statistical power in differential expression
inference [23]. This approach respects the original design of the
array, and uses a statistical model to incorporate measurements
from all redundant (termed sibling) probe sets, but only when the
probe sets behave similarly in an experiment based on the
insignificant result from testing the interaction term. In their
article presenting the approach, Li and co-workers showed that
their strategy has greater power to detect differentially expressed
genes than individual probe set analysis or the consolidated ‘‘mega
probe set’’ strategy. Their work differs from ours in that we focus
on the differences between redundant probe sets, aiming to
identify candidates for regulated alternative mRNA processing. Li
et al focus on detecting differential expression of the entire target
gene and use redundant probe sets only when they respond the
same way to an experimental treatment. In general, most
approaches that attempt to handle redundant probe sets are
aimed either at using them to improve gene-level inference or
detect novel splice variants. Our approach, by contrast, aims to
detect candidates for differential regulation of mRNA processing,
using what is already known about the genomic landscape and
respecting the original Affymetrix design, which, although
imperfect, reflects the known universe of mRNA transcripts.
In addition to probe set-to-target-gene mappings, Affymetrix
assigns a grade to each probe set according to how well it matches
a designated target transcript, independent from the Entrez Gene
annotations. The probe set grades are based on sequence analysis
comparing probes to their annotated targets. Although valuable,
they do not specifically address the redundancy of probe sets but
instead describe how well a probe set’s constituent probes match a
transcript (mRNA) record. For the purposes of redundant probe
set assignments and examining alternative splicing/polyadenyla-
tion, it is better to examine the exon-intron structure of target
mRNAs via their genomic alignments, since ultimately these are
what biologists and data analysts will use to assess whether a given
pair of probes sets interrogate an alternatively spliced or
polyadenylated gene.
It is important to note that Affymetrix continues to develop new
array designs, such as exon-focused arrays in which probes are
selected from all known exons, and, more recently, reduced genome
exon arrays which query all known exons but use fewer probes per
target gene. However, the continuing popularity of the three-prime
arrays and availability of large amounts of archived expression data
in resources such as the Gene Expression Omnibus argue in favour
of continued exploration of new analysis methods. The redundant
probe sets on the three-prime arrays offer a means to measure
differential three-prime end processing, e.g., alternative terminal
exon choice and alternative polyadenylation. We expect that in the
future, the exon arrays (or specialized splicing arrays) will be the tool
ofchoiceto measuredifferentialmRNAsplicing,whiledatafrom the
three-prime arrays will get a second life as a rich source for data-
mining alternative three-prime end processing mechanisms. Ulti-
mately, the analysis procedures demonstrated here can be applied to
multiple data sets to reveal large-scale patterns of alternative mRNA
production and regulation.
Supporting Information
Data S1 Genome-screened redundant probe sets. This file
reports Entrez Gene targets (when available) and genome-screened
redundant probe sets. Each row lists a set of redundant probe sets.
Column 1 gives the Entrez Gene id; column 2 gives a GenBank
accession for a mRNA overlapping the region; column 3 reports
the group type; and column 4 contains a comma-separated list of
redundant probe set ids. All probe set ids are from the mouse
MOE430_2 array from Affymetrix. Group type (column 3)
designation ‘‘overlap’’ indicates that the probe sets all match the
same Entrez Gene. Group type ‘‘mixed_overlap’’ indicates that
some probe sets within a group map onto more than one Entrez
Gene id. This can occur when a first exon in one gene overlaps the
last exon in another.
Found at: doi:10.1371/journal.pone.0004229.s001 (0.28 MB
TXT)
Data S2 Probe set screening results. This tab-delimited spread-
sheet lists every probe set on the mouse 430_2 array from
Affymetrix. Column 1 gives the name of the probe set; column 2
(labeled ‘‘map’’) reports whether the probe set maps to one (SM),
more than one (MM) or no (NM) locations in the mm8 mouse
genome assembly; and the third column (labeled ‘‘probes’’) reports
the number of probes per probe set that map to the genome for all
probe sets designated SM in column 2.
Found at: doi:10.1371/journal.pone.0004229.s002 (0.78 MB
TXT)
Data S3 Plots Showing Differentially Expressed Probe Sets. This
file contains plots summarizing differential expression analysis
results for the two subsets of data from GSE4035. Each fear
condition level was treated as one data set after data pre-
processing. The two brain regions were compared to identify
differentially-expressed probe sets.
Found at: doi:10.1371/journal.pone.0004229.s003 (0.06 MB
DOC)
Data S4 Redundant Probe Set Consistency with Respect to
Differential Expression. This file (divided into four sections) reports
the number of significant probe sets for genes interrogated by
redundant probe sets established using different grouping methods
Redundant Probe Sets Analysis
PLoS ONE | www.plosone.org 10 January 2009 | Volume 4 | Issue 1 | e4229with or without removing the absent probe sets. Only genes with at
least one differentially-expressed probe set are included.
Found at: doi:10.1371/journal.pone.0004229.s004 (0.00 MB
TXT)
Data S5 Effects of Varying Present/Absent Alpha Level. This
file reports the effects of altering P/A call expected false positive
alpha rate settings on redundant probe set consistency.
Found at: doi:10.1371/journal.pone.0004229.s005 (0.01 MB
XLS)
Data S6 Significance Consistency Results. Plots illustrating how
significance consistency varies with respect to the false positive
alpha rate setting for P/A calls.
Found at: doi:10.1371/journal.pone.0004229.s006 (0.06 MB
DOC)
Data S7 Gene Structure Inspection Results. Results from
manual inspection of gene structures using the Integrated Genome
Browser for the 70 genes with two present redundant probe sets
that show significant different fold changes between two brain
regions.
Found at: doi:10.1371/journal.pone.0004229.s007 (0.03 MB
XLS)
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